610 Unfiltered Template Results

(You need to login as owner of this project to build models)
ModelsNameDescriptionGMQEQSQESeq IdCoverageRangeMethodResolutionOligo-stateLigandsFound bySeq Similarity
7dwx.1
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.770.5899.901.00 2-805
1-1273		EM0.00hetero-6-2-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dwx.1
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.7799.901.00 2-805
1-1273		EM0.00hetero-6-2-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dx5.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-1-mer29 x NAG, 26 x NAG-NAGHHblits0.62
7dx5.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
0.7199.901.00 2-805
1-1273		EM0.00hetero-3-1-mer29 x NAG, 26 x NAG-NAGHHblits0.62
7dx6.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx6.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
0.7199.901.00 2-805
1-1273		EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx7.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.7099.901.00 2-805
1-1273		EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx7.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.7199.901.00 2-805
1-1273		EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx9.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx9.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.7299.901.00 2-805
1-1273		EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.7098.121.00 1-805
1-1273		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.7098.121.00 1-805
1-1273		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.61
7xo8.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.7198.121.00 1-805
1-1273		EM0.00hetero-3-3-mer39 x NAG, 3 x ZNHHblits0.61
7xo9.1
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2
0.3198.121.00 1-805
1-1273		EM0.00hetero-1-1-mer1 x ZN, 3 x NAGHHblits0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.7098.210.99 1-805
12-1273		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST / HHblits0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.7098.210.99 1-805
12-1273		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST / HHblits0.61
7xo8.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.7198.210.99 1-805
12-1273		EM0.00hetero-3-3-mer39 x NAG, 3 x ZNBLAST / HHblits0.61
7xoa.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.6991.181.00 1-805
1-1273		EM0.00hetero-3-1-mer34 x NAG, 1 x ZNHHblits0.59
7xob.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
0.7091.181.00 1-805
1-1273		EM0.00hetero-3-2-mer37 x NAG, 2 x ZNHHblits0.59
7xob.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
0.7091.181.00 1-805
1-1273		EM0.00hetero-3-2-mer37 x NAG, 2 x ZNHHblits0.59
7xoc.1
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2
0.3091.181.00 1-805
1-1273		EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGHHblits0.59
7xoa.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.7091.230.99 1-805
12-1273		EM0.00hetero-3-1-mer34 x NAG, 1 x ZNBLAST / HHblits0.59
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6097.710.97 1-805
1-1208		EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGHHblits0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6097.710.97 1-805
1-1208		EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGHHblits0.61
7wpb.1
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
0.3197.710.97 1-805
1-1208		EM0.00hetero-1-1-mer3 x NAG, 1 x ZNHHblits0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.3097.710.97 1-805
1-1208		EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGHHblits0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.3097.710.97 1-805
1-1208		EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGHHblits0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
0.6897.510.97 2-805
1-1208		EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGHHblits0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
0.6897.510.97 2-805
1-1208		EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGHHblits0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6098.250.96 1-805
12-1208		EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGBLAST / HHblits0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6098.250.96 1-805
12-1208		EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGBLAST / HHblits0.61
7wpb.1
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
0.3198.250.96 1-805
12-1208		EM0.00hetero-1-1-mer3 x NAG, 1 x ZNBLAST / HHblits0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.3098.250.96 1-805
12-1208		EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGBLAST / HHblits0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.3098.250.96 1-805
12-1208		EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGBLAST / HHblits0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
0.6898.050.96 2-805
12-1208		EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGBLAST / HHblits0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
0.6998.050.96 2-805
12-1208		EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGBLAST / HHblits0.61
8dv2.1
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
0.3299.590.93 18-740
1-1208		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
8dv1.1
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
0.3299.530.93 18-740
1-1208		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.650.4290.530.97 1-805
1-1208		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.650.4290.530.97 1-805
1-1208		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6090.530.97 1-805
1-1208		EM0.00hetero-3-1-mer37 x NAG, 1 x ZNHHblits0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6190.530.97 1-805
1-1208		EM0.00hetero-3-1-mer37 x NAG, 1 x ZNHHblits0.59
7xo6.1
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
0.3090.530.97 1-805
1-1208		EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGHHblits0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6591.030.96 1-805
12-1208		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST / HHblits0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6591.030.96 1-805
12-1208		EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST / HHblits0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6091.030.96 1-805
12-1208		EM0.00hetero-3-1-mer37 x NAG, 1 x ZNBLAST / HHblits0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6191.030.96 1-805
12-1208		EM0.00hetero-3-1-mer37 x NAG, 1 x ZNBLAST / HHblits0.59
7xo6.1
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
0.2991.030.96 1-805
12-1208		EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGBLAST / HHblits0.59
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.7099.890.90 19-615
1-1273		EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST / HHblits0.62
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.7099.890.90 19-615
1-1273		EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST / HHblits0.62
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.7099.890.90 19-615
1-1273		EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST / HHblits0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5899.370.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5899.370.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5999.370.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5899.010.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST / HHblits0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5899.010.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST / HHblits0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.5999.010.92 18-740
15-1208		EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST / HHblits0.62
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
0.6597.740.90 19-612
1-1273		EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST / HHblits0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6797.480.90 19-615
1-1273		EM3.30hetero-3-1-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.480.90 19-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6997.480.90 19-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6997.480.90 19-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
0.6597.740.90 20-612
1-1273		EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6797.480.90 20-615
1-1273		EM3.30hetero-3-1-mer1 x ZN, 48 x NAG, 9 x NAG-NAGHHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.480.90 20-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6997.480.90 20-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6997.480.90 20-615
1-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
0.2997.580.90 19-612
1-1273		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
0.2997.580.90 20-612
1-1273		EM0.00hetero-1-1-mer5 x NAGHHblits0.61
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
0.6598.270.89 19-612
12-1273		EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.62
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
0.6598.270.89 20-612
12-1273		EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST / HHblits0.62
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6697.740.89 19-615
12-1273		EM3.30hetero-3-1-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 19-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 19-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 19-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6697.740.89 20-615
12-1273		EM3.30hetero-3-1-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 20-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 20-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6897.740.89 20-615
12-1273		EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST / HHblits0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
0.2898.110.89 19-612
12-1273		EM0.00hetero-1-1-mer5 x NAGBLAST0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
0.2898.110.89 20-612
12-1273		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.61
7v85.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6999.340.88 1-615
1-1207		EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGHHblits0.62
7v86.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.7199.340.88 1-615
1-1207		EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGHHblits0.62
7v87.1
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.3099.340.88 1-615
1-1207		EM0.00hetero-1-1-mer4 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.7099.120.88 1-615
1-1207		EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.7099.120.88 1-615
1-1207		EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7v82.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7099.120.88 1-615
1-1207		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.62
7v83.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7099.120.88 1-615
1-1207		EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGHHblits0.62
7v84.1
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.3199.120.88 1-615
1-1207		EM0.00hetero-1-1-mer3 x NAG, 5 x NAG-NAGHHblits0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6999.230.88 1-615
1-1207		EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6999.230.88 1-615
1-1207		EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.230.88 1-615
1-1207		EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.62
7v89.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7099.230.88 1-615
1-1207		EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGHHblits0.62
7v8a.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6999.230.88 1-615
1-1207		EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGHHblits0.62
7v8b.1
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.3199.230.88 1-615
1-1207		EM0.00hetero-1-1-mer3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6999.890.87 19-615
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6999.890.87 19-615
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6999.890.87 19-615
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6499.890.87 19-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6499.890.87 19-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6499.890.87 19-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7a96.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6499.890.87 19-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7a96.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6399.890.87 19-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6599.890.87 19-615
1-1208		EM0.00hetero-3-2-merHHblits0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6599.890.87 19-615
1-1208		EM0.00hetero-3-2-merHHblits0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6499.890.87 19-615
1-1208		EM0.00hetero-3-2-merHHblits0.62
7a98.1
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
0.6399.890.87 19-615
1-1208		EM0.00hetero-3-3-merHHblits0.62
7df4.1
SARS-CoV-2 S-ACE2 complex
0.6899.720.87 17-615
1-1208		EM0.00hetero-3-1-mer36 x NAG, 18 x NAG-NAGHHblits0.62
7df4.1
SARS-CoV-2 S-ACE2 complex
0.6899.720.87 17-615
1-1208		EM0.00hetero-3-1-mer36 x NAG, 18 x NAG-NAGHHblits0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6899.720.87 19-615
1-1208		EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGBLAST / HHblits0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6899.720.87 19-615
1-1208		EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGBLAST / HHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.720.87 19-615
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.720.87 19-615
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6699.720.87 19-615
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6499.720.87 19-615
1-1208		EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGBLAST / HHblits0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6299.720.87 19-615
1-1208		EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGBLAST / HHblits0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6399.720.87 19-615
1-1208		EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGBLAST / HHblits0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6499.720.87 19-615
1-1208		EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGBLAST / HHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.720.87 19-615
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.720.87 19-615
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6499.720.87 19-615
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST / HHblits0.62
7kni.1
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6699.720.87 19-615
1-1208		EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGBLAST / HHblits0.62
7v7z.1
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6898.960.88 1-615
1-1207		EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGHHblits0.62
7v80.1
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.2998.960.88 1-615
1-1207		EM0.00hetero-1-1-mer5 x NAG, 3 x NAG-NAGHHblits0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6899.720.87 20-614
1-1208		EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGHHblits0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6899.720.87 20-614
1-1208		EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGHHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.720.87 20-614
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.720.87 20-614
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6699.720.87 20-614
1-1208		EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6399.720.87 20-614
1-1208		EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGHHblits0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6299.720.87 20-614
1-1208		EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGHHblits0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6399.720.87 20-614
1-1208		EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGHHblits0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6399.720.87 20-614
1-1208		EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGHHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.720.87 20-614
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.720.87 20-614
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6499.720.87 20-614
1-1208		EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.62
7kni.1
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6799.720.87 20-614
1-1208		EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGHHblits0.62
7yeg.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6399.500.87 19-615
1-1208		EM0.00hetero-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGBLAST / HHblits0.62
✓
7mjm.1
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7499.450.87 18-615
1-1208		EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7vx5.1
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
0.3199.390.87 17-615
1-1208		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.7099.390.87 17-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.7099.390.87 17-615
1-1208		EM0.00hetero-3-1-merHHblits0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
0.7099.390.87 17-615
1-1208		EM3.90hetero-3-1-merHHblits0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
0.7199.390.87 17-615
1-1208		EM3.90hetero-3-1-merHHblits0.62
7vxc.1
SARS-CoV-2 Kappa variant spike protein in C3 state
0.7099.390.87 17-615
1-1208		EM3.90hetero-3-1-merHHblits0.62
7sxx.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6499.450.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7sxx.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.450.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7sxy.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3399.450.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7mjn.1
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3299.450.87 19-615
1-1208		EM0.00hetero-1-1-mer5 x NAGHHblits0.62
7sxz.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6599.390.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
7sxz.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.390.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
7sy0.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3399.390.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7yeg.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6399.500.87 20-614
1-1208		EM0.00hetero-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGHHblits0.62
7sy1.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6599.390.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
7sy1.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.390.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
7sy2.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3399.390.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7v85.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6999.340.87 1-615
12-1208		EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGBLAST / HHblits0.62
7v86.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.7199.340.87 1-615
12-1208		EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGBLAST / HHblits0.62
7sy7.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6599.280.87 18-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7sy7.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.280.87 18-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6599.340.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.340.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.6599.340.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7sy4.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3299.340.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7sy5.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7499.280.87 19-615
1-1208		EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.62
7sy6.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3399.280.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7sy8.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.3299.280.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7w98.1
SARS-CoV-2 Delta S-ACE2-C1
0.7099.330.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7w99.1
SARS-CoV-2 Delta S-ACE2-C2a
0.7099.330.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7w9b.1
SARS-CoV-2 Delta S-ACE2-C2b
0.7199.330.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7w9c.1
SARS-CoV-2 Delta S-ACE2-C3
0.7199.330.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7r12.1
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.3499.440.87 19-613
1-1208		EM0.00hetero-1-1-mer1 x ZN, 6 x NAGHHblits0.62
7tez.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3399.170.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.6599.170.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.7599.170.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.7099.120.87 1-615
12-1208		EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMABLAST / HHblits0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.7099.120.87 1-615
12-1208		EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMABLAST / HHblits0.62
7v82.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7099.120.87 1-615
12-1208		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST / HHblits0.62
7v83.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7099.120.87 1-615
12-1208		EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGBLAST / HHblits0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.7099.280.87 1-615
12-1208		EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGBLAST / HHblits0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6999.280.87 1-615
12-1208		EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGBLAST / HHblits0.62
7v89.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7099.280.87 1-615
12-1208		EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGBLAST / HHblits0.62
7v8a.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7199.280.87 1-615
12-1208		EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGBLAST / HHblits0.62
7v8b.1
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.3099.280.87 1-615
12-1208		EM0.00hetero-1-1-mer3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAGBLAST / HHblits0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.6599.000.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.7499.000.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.6499.000.87 19-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
8dln.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3399.000.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.6599.060.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.7499.060.87 19-615
1-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.62
8dlk.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3399.060.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7v7z.1
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6999.230.87 1-615
12-1208		EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGBLAST / HHblits0.62
7v80.1
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.2899.230.87 1-615
12-1208		EM0.00hetero-1-1-mer5 x NAG, 3 x NAG-NAGBLAST / HHblits0.62
8dlp.1
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7498.840.87 19-615
1-1208		EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.62
8dlq.1
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3398.840.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
8dlu.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7499.060.87 19-615
1-1208		EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGHHblits0.62
8dlv.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3299.060.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
✓
7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.7299.670.87 12-615
14-1208		EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGBLAST / HHblits0.62
7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.7199.670.87 12-615
14-1208		EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGBLAST / HHblits0.62
7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.7199.670.87 12-615
14-1208		EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGBLAST / HHblits0.62
7r10.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
0.5199.220.87 19-613
1-1208		EM0.00hetero-1-1-mer1 x ZN, 7 x NAGHHblits0.62
7r0z.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.3499.170.87 19-613
1-1208		EM0.00hetero-1-1-mer1 x ZN, 8 x NAGHHblits0.62
7kj3.1
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
0.7299.670.87 13-615
14-1208		EM0.00hetero-3-2-mer40 x NAG, 20 x NAG-NAGHHblits0.62
7kj3.1
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
0.7199.670.87 13-615
14-1208		EM0.00hetero-3-2-mer40 x NAG, 20 x NAG-NAGHHblits0.62
7kj4.1
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
0.7199.670.87 13-615
14-1208		EM0.00hetero-3-3-mer42 x NAG, 24 x NAG-NAGHHblits0.62
7r1a.1
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
0.7099.170.87 19-613
1-1208		EM0.00hetero-3-3-mer48 x NAG, 3 x ZN, 3 x NAG-NAGHHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6799.390.87 1-615
16-1208		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST / HHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6799.390.87 1-615
16-1208		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST / HHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6899.390.87 1-615
16-1208		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST / HHblits0.62
7tew.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3399.060.87 19-615
1-1206		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
7tex.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
0.6599.060.87 19-615
1-1206		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
7tex.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
0.7499.060.87 19-615
1-1206		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.62
8aqs.1
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
0.3097.680.87 19-620
1-1212		EM0.00hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.61
7r11.1
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.3399.000.87 19-613
1-1208		EM0.00hetero-1-1-mer7 x NAG, 1 x ZNHHblits0.62
7vx4.1
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
0.3198.950.87 17-615
1-1206		EM3.90hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6898.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6798.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.7098.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6998.950.87 17-615
1-1206		EM0.00hetero-3-1-merHHblits0.62
7vx5.1
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
0.3199.390.86 17-615
12-1208		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.7099.390.86 17-615
12-1208		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.7099.390.86 17-615
12-1208		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
0.7199.390.86 17-615
12-1208		EM3.90hetero-3-1-merBLAST / HHblits0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
0.7199.390.86 17-615
12-1208		EM3.90hetero-3-1-merBLAST / HHblits0.62
7vxc.1
SARS-CoV-2 Kappa variant spike protein in C3 state
0.7099.390.86 17-615
12-1208		EM3.90hetero-3-1-merBLAST / HHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6799.060.87 1-615
16-1207		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6699.060.87 1-615
16-1207		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6799.060.87 1-615
16-1207		EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.62
7w98.1
SARS-CoV-2 Delta S-ACE2-C1
0.7099.330.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7w99.1
SARS-CoV-2 Delta S-ACE2-C2a
0.7099.330.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7w9b.1
SARS-CoV-2 Delta S-ACE2-C2b
0.7099.330.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7w9c.1
SARS-CoV-2 Delta S-ACE2-C3
0.7099.330.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
8dlu.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7599.280.86 19-615
12-1208		EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7tez.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3299.160.86 19-615
12-1208		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.6699.160.86 19-615
12-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7kmb.1
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4
0.2999.720.86 20-614
16-1208		EM0.00hetero-1-1-mer5 x NAG, 2 x NAG-NAGHHblits0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.7499.110.86 19-615
12-1208		EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST / HHblits0.62
7r10.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
0.5199.550.86 19-613
12-1208		EM0.00hetero-1-1-mer1 x ZN, 7 x NAGBLAST / HHblits0.62
7r11.1
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.3299.270.86 19-613
12-1208		EM0.00hetero-1-1-mer7 x NAG, 1 x ZNBLAST / HHblits0.62
7vx4.1
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
0.3199.220.86 17-615
12-1206		EM3.90hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6899.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6899.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.7199.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6999.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6999.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.7099.220.86 17-615
12-1206		EM0.00hetero-3-1-merBLAST / HHblits0.62
8dm5.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
0.7497.830.87 19-615
1-1208		EM0.00hetero-3-2-mer33 x NAG, 18 x NAG-NAGHHblits0.61
8dm5.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
0.7497.830.87 19-615
1-1208		EM0.00hetero-3-2-mer33 x NAG, 18 x NAG-NAGHHblits0.61
8dm6.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3297.830.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7tew.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3299.110.86 19-615
12-1206		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
8aqs.1
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
0.2997.940.87 19-620
12-1208		EM0.00hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.61
7wk6.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
0.3197.450.87 17-615
1-1208		EM0.00hetero-1-1-merHHblits0.61
7wvp.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
0.6497.450.87 17-615
1-1208		EM0.00hetero-3-1-merHHblits0.61
7wvp.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
0.6497.450.87 17-615
1-1208		EM0.00hetero-3-1-merHHblits0.61
7wvq.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.6297.450.87 17-615
1-1208		EM0.00hetero-3-1-merHHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.440.87 19-614
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST / HHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.440.87 19-614
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST / HHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.440.86 20-613
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.440.86 20-613
1-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6797.440.87 17-615
1-1205		EM0.00hetero-3-1-merHHblits0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6797.440.87 17-615
1-1205		EM0.00hetero-3-1-merHHblits0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6497.440.87 17-615
1-1205		EM0.00hetero-3-1-merHHblits0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6497.440.87 17-615
1-1205		EM0.00hetero-3-1-merHHblits0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.7497.220.87 19-615
1-1208		EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGHHblits0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.6597.220.87 19-615
1-1208		EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGHHblits0.61
7t9l.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.3397.220.87 19-615
1-1208		EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.220.86 19-613
1-1208		EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST / HHblits0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.220.86 19-613
1-1208		EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST / HHblits0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.220.86 20-613
1-1208		EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGHHblits0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.220.86 20-613
1-1208		EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGHHblits0.61
7wk6.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
0.3198.040.86 17-615
12-1208		EM0.00hetero-1-1-merBLAST / HHblits0.61
7wvq.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.6198.040.86 17-615
12-1208		EM0.00hetero-3-1-merBLAST / HHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.990.86 19-614
12-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.990.86 19-614
12-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7098.150.86 19-614
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7098.150.86 19-614
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6798.040.86 17-615
12-1205		EM0.00hetero-3-1-merBLAST / HHblits0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6798.040.86 17-615
12-1205		EM0.00hetero-3-1-merBLAST / HHblits0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6498.040.86 17-615
12-1205		EM0.00hetero-3-1-merBLAST / HHblits0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6498.040.86 17-615
12-1205		EM0.00hetero-3-1-merBLAST / HHblits0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.7497.820.86 19-615
12-1208		EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGBLAST / HHblits0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.6597.820.86 19-615
12-1208		EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGBLAST / HHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.980.86 20-613
12-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST / HHblits0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7097.980.86 20-613
12-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST / HHblits0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7098.150.86 20-613
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST / HHblits0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7098.150.86 20-613
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST / HHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7097.980.86 19-614
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7197.980.86 19-614
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.820.86 19-613
12-1208		EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.820.86 19-613
12-1208		EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.820.86 20-613
12-1208		EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST / HHblits0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7397.820.86 20-613
12-1208		EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST / HHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7097.980.86 20-613
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST / HHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7197.980.86 20-613
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST / HHblits0.61
8aqt.1
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.1693.220.87 19-623
1-1212		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.60
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7097.590.86 19-614
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST / HHblits0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7097.590.86 19-614
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST / HHblits0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7097.590.86 20-613
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGHHblits0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7097.590.86 20-613
14-1208		EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGHHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7097.420.86 19-614
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST / HHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7197.420.86 19-614
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST / HHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7097.420.86 20-613
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGHHblits0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.7197.420.86 20-613
14-1208		EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGHHblits0.61
8dm7.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7392.630.88 1-615
1-1208		EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGHHblits0.59
8dm8.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
0.3192.630.88 1-615
1-1208		EM0.00hetero-1-1-mer3 x NAGHHblits0.59
8aqv.1
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2892.220.87 19-623
1-1212		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.59
8aqt.1
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.1793.660.87 19-623
12-1208		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST / HHblits0.60
8dm9.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7392.020.87 1-615
1-1208		EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.59
8dma.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
0.3292.020.87 1-615
1-1208		EM0.00hetero-1-1-mer3 x NAGHHblits0.59
8dm7.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7492.700.87 1-615
12-1208		EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGBLAST / HHblits0.59
8aqw.1
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2792.250.87 19-618
1-1212		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.59
8aqu.1
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2091.660.87 19-623
1-1212		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.59
8aqv.1
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2892.500.87 19-623
12-1208		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST / HHblits0.59
8aqu.1
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2092.430.86 19-623
12-1208		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST / HHblits0.59
8aqw.1
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.2792.690.86 19-618
12-1208		EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST / HHblits0.59
7wrh.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.700.5592.550.86 18-615
15-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.59
7wri.1
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
0.2992.710.86 18-615
14-1205		EM0.00hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.60
7wrh.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7091.940.86 18-615
15-1208		EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST / HHblits0.59
7wri.1
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
0.2992.100.86 18-615
14-1205		EM0.00hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.59
7dqa.1
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
0.3599.900.48 1-805
335-526		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.7099.650.83 19-615
14-1146		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.6999.650.83 19-615
14-1146		EM0.00hetero-3-1-merBLAST / HHblits0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.7099.650.83 20-614
14-1146		EM0.00hetero-3-1-merHHblits0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.6999.650.83 20-614
14-1146		EM0.00hetero-3-1-merHHblits0.62
7dqa.1
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
0.3599.900.48 1-805
333-526		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.400.48 1-805
329-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.400.48 1-805
329-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.400.48 1-805
329-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.400.48 1-805
329-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.700.48 1-805
328-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGBLAST / HHblits0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3599.700.48 1-805
328-529		X-ray2.70hetero-1-1-mer2 x ZN, 13 x NAG, 2 x NAG-NAGBLAST / HHblits0.62
7l7f.1
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
0.380.3398.920.49 1-805
319-532		EM0.00hetero-2-2-merHHblits0.62
6m17.1
The 2019-nCoV RBD/ACE2-B0AT1 complex
0.4199.900.49 2-805
319-541		EM0.00hetero-2-2-mer10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
6m17.1
The 2019-nCoV RBD/ACE2-B0AT1 complex
0.41100.000.49 2-805
319-541		EM0.00hetero-2-2-mer10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAGBLAST / HHblits0.62
7y75.1
SIT1-ACE2-BA.2 RBD
0.410.2598.440.49 2-805
319-541		EM0.00hetero-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.62
7y76.1
SIT1-ACE2-BA.5 RBD
0.4198.340.49 2-805
319-541		EM0.00hetero-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.62
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.630.5284.550.86 19-615
1-1214		EM0.00hetero-3-1-merBLAST / HHblits0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6484.550.86 19-615
1-1214		EM0.00hetero-3-1-merBLAST / HHblits0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6384.540.86 20-615
1-1214		EM0.00hetero-3-1-merHHblits0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6484.540.86 20-615
1-1214		EM0.00hetero-3-1-merHHblits0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6285.260.85 19-615
26-1214		EM0.00hetero-3-1-merBLAST0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6385.260.85 19-615
26-1214		EM0.00hetero-3-1-merBLAST0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6285.250.85 20-615
26-1214		EM0.00hetero-3-1-merBLAST / HHblits0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.6385.250.85 20-615
26-1214		EM0.00hetero-3-1-merBLAST / HHblits0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6185.040.85 19-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6885.040.85 19-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6185.040.85 19-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6084.730.85 19-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6784.730.85 19-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6084.730.85 19-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6185.030.85 20-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6885.030.85 20-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6185.030.85 20-615
26-1208		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST / HHblits0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6084.720.85 20-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6784.720.85 20-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6084.720.85 20-615
25-1212		EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.57
7wsg.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with sea lion ACE2
0.3281.130.47 1-804
335-516		EM0.00hetero-1-1-mer1 x ZNHHblits0.56
7wsh.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
0.3486.560.48 1-804
335-527		EM0.00hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.58
7wsh.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
0.340.5186.590.48 1-804
333-527		EM0.00hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7xby.1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
0.3487.820.49 1-805
319-541		X-ray2.85hetero-1-1-mer1 x ZN, 6 x BR, 1 x NAGHHblits0.58
7xby.1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
0.350.5088.230.49 1-805
319-541		X-ray2.85hetero-1-1-mer1 x ZN, 6 x BR, 1 x NAGBLAST / HHblits0.59
7wnm.1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
0.3699.380.46 1-740
319-541		X-ray2.70hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.62
7wnm.1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
0.3699.480.46 1-740
319-541		X-ray2.70hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.62
7wsf.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2
0.3581.100.44 1-740
335-516		EM0.00hetero-1-1-mer1 x ZNHHblits0.56
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.3586.910.45 1-740
335-527		EM0.00hetero-1-1-mer1 x ZNHHblits0.58
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.3586.940.45 1-740
333-527		EM0.00hetero-1-1-mer1 x ZNBLAST / HHblits0.58
7wsf.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2
0.3581.200.43 12-740
335-516		EM0.00hetero-1-1-mer1 x ZNBLAST / HHblits0.56
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.3588.970.44 18-740
335-527		EM0.00hetero-1-1-mer1 x ZNBLAST / HHblits0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.350.5889.000.44 18-740
333-527		EM0.00hetero-1-1-mer1 x ZNBLAST0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.3588.960.44 19-740
335-527		EM0.00hetero-1-1-mer1 x ZNHHblits0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.3588.990.44 19-740
333-527		EM0.00hetero-1-1-mer1 x ZNBLAST / HHblits0.59
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.3587.080.44 12-740
335-527		EM0.00hetero-1-1-mer1 x ZNBLAST / HHblits0.58
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.350.6287.110.44 12-740
333-527		EM0.00hetero-1-1-mer1 x ZNBLAST0.58
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.3887.980.44 18-740
335-527		X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.390.5688.000.44 18-740
333-527		X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.3887.650.44 19-740
335-527		X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.3887.680.44 19-740
333-527		X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.59
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.3784.780.43 20-726
335-527		X-ray3.18hetero-1-1-mer1 x ZNBLAST / HHblits0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.370.5184.810.43 20-726
333-527		X-ray3.18hetero-1-1-mer1 x ZNBLAST0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.3784.760.43 21-726
335-527		X-ray3.18hetero-1-1-mer1 x ZNHHblits0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.3784.790.43 21-726
333-527		X-ray3.18hetero-1-1-mer1 x ZNBLAST / HHblits0.58
7wpo.1
Structure of NeoCOV RBD binding to Bat37 ACE2
0.3467.100.41 20-714
330-497		EM0.00hetero-1-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-FUCBLAST / HHblits0.51
7wpo.1
Structure of NeoCOV RBD binding to Bat37 ACE2
0.3466.820.41 21-714
330-497		EM0.00hetero-1-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.50
7a91.1
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.41100.000.61 19-613
1-679		EM0.00hetero-1-1-mer7 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7a92.1
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement)
0.53100.000.61 19-613
1-676		EM0.00hetero-1-1-mer7 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7fdg.1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
0.3599.880.39 1-615
333-526		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7fdh.1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
0.3699.750.39 1-615
333-526		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7fdi.1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
0.3699.630.39 1-615
333-526		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7fdg.1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
0.3599.630.39 1-615
332-526		EM0.00hetero-1-1-mer5 x NAGHHblits0.63
7fdh.1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
0.3699.510.39 1-615
332-526		EM0.00hetero-1-1-mer5 x NAGHHblits0.63
7fdi.1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
0.3699.380.39 1-615
332-526		EM0.00hetero-1-1-mer5 x NAGHHblits0.63
7sn0.1
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.3799.160.40 1-615
319-541		X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAGHHblits0.62
7sn0.2
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.3699.160.40 1-615
319-541		X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAGHHblits0.62
7sn0.1
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.3799.280.40 1-615
319-541		X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAGBLAST / HHblits0.62
7sn0.2
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.3699.280.40 1-615
319-541		X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAGBLAST / HHblits0.62
2ajf.1
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
0.3393.480.37 19-615
336-516		X-ray2.90hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-BMABLAST / HHblits0.61
3scj.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2
0.3393.480.37 19-615
336-516		X-ray3.00hetero-1-1-mer1 x ZNBLAST / HHblits0.61
3scj.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2
0.3393.470.37 20-615
336-516		X-ray3.00hetero-1-1-mer1 x ZNHHblits0.61
2ajf.1
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
0.3393.460.37 20-614
336-516		X-ray2.90hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-BMAHHblits0.61
7w9i.1
SARS-CoV-2 Delta S-RBD-ACE2
0.3498.860.38 17-615
335-526		EM0.00hetero-1-1-merHHblits0.62
7w9i.1
SARS-CoV-2 Delta S-RBD-ACE2
0.3699.750.38 17-615
333-526		EM0.00hetero-1-1-merBLAST / HHblits0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
0.36100.000.38 19-615
335-526		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7ydi.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
0.34100.000.38 19-615
335-526		EM0.00hetero-1-1-mer1 x ZN, 4 x NAGBLAST / HHblits0.63
3d0g.1
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
0.330.1692.350.37 19-615
337-516		X-ray2.80hetero-2-2-mer5 x NDG, 2 x ZN, 1 x NAGBLAST / HHblits0.60
7ydi.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
0.34100.000.38 19-615
334-526		EM0.00hetero-1-1-mer1 x ZN, 4 x NAGBLAST0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
0.36100.000.38 19-615
333-526		EM0.00hetero-1-1-mer5 x NAGBLAST0.63
3sck.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
0.3392.220.37 19-615
337-516		X-ray3.00hetero-1-1-mer1 x ZNBLAST / HHblits0.60
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.3699.490.38 19-615
335-528		X-ray3.14hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7whh.1
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
0.350.5697.720.38 19-615
335-526		X-ray2.60hetero-1-1-mer1 x ZN, 4 x NAG, 1 x NAG-FUC-NAGBLAST / HHblits0.62
3sck.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
0.3392.210.37 20-615
337-516		X-ray3.00hetero-1-1-mer1 x ZNHHblits0.60
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.3699.500.38 19-615
333-528		X-ray3.14hetero-1-1-mer5 x NAGBLAST0.63
7vib.1
Crystal structure of human ACE2 and GX/P2V RBD
0.350.6096.830.38 19-615
335-526		X-ray3.20hetero-1-1-mer1 x ZNBLAST / HHblits0.62
7vib.2
Crystal structure of human ACE2 and GX/P2V RBD
0.3496.830.38 19-615
335-526		X-ray3.20hetero-1-1-mer1 x ZNBLAST / HHblits0.62
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.3699.490.38 20-615
335-528		X-ray3.14hetero-1-1-mer5 x NAGHHblits0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
0.36100.000.38 20-614
335-526		EM0.00hetero-1-1-mer5 x NAGHHblits0.63
7bh9.1
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
0.3598.870.38 19-615
333-528		EM0.00hetero-1-1-mer1 x ZN, 3 x NAGBLAST / HHblits0.63
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.3599.240.38 19-614
335-528		X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.63
7whh.1
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
0.3597.710.38 19-614
335-526		X-ray2.60hetero-1-1-mer1 x ZN, 4 x NAG, 1 x NAG-FUC-NAGHHblits0.62
3d0g.1
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
0.330.1692.330.37 20-614
337-516		X-ray2.80hetero-2-2-mer5 x NDG, 2 x ZN, 1 x NAGHHblits0.60
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.340.6298.100.38 19-614
335-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.340.5597.720.38 19-614
335-527		X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMABLAST / HHblits0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.3497.720.38 19-614
335-527		EM0.00hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.3597.720.38 19-614
335-527		EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGBLAST / HHblits0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.3597.720.38 19-614
335-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.3699.870.38 19-614
335-530		X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCBLAST / HHblits0.63
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.3699.490.38 20-615
333-528		X-ray3.14hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
0.36100.000.38 20-614
333-526		EM0.00hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.340.6298.480.38 19-614
333-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.3599.240.38 19-614
332-528		X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.63
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.3699.870.38 19-614
333-530		X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCBLAST0.63
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.3498.100.38 19-614
333-527		X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMABLAST0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.3598.100.38 19-614
333-527		EM0.00hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.3598.100.38 19-614
333-527		EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGBLAST0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.3598.100.38 19-614
333-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.3599.880.38 19-615
328-530		X-ray2.78hetero-1-1-mer1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST / HHblits0.63
7vib.1
Crystal structure of human ACE2 and GX/P2V RBD
0.3596.820.38 20-614
335-526		X-ray3.20hetero-1-1-mer1 x ZNHHblits0.62
7vib.2
Crystal structure of human ACE2 and GX/P2V RBD
0.340.5396.820.38 20-614
335-526		X-ray3.20hetero-1-1-mer1 x ZNHHblits0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.3599.240.38 20-613
335-528		X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.3599.880.39 19-615
328-531		X-ray2.78hetero-1-1-mer1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.63
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.340.6298.090.38 20-613
335-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.3497.710.38 20-613
335-527		X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMAHHblits0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.3497.710.38 20-613
335-527		EM0.00hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.3597.710.38 20-613
335-527		EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGHHblits0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.3597.710.38 20-613
335-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.3699.870.38 20-613
335-530		X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCHHblits0.63
7xaz.1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.3597.580.38 20-613
335-527		X-ray3.00hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.62
7xaz.2
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.3597.580.38 20-613
335-527		X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7xb0.1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
0.3497.970.38 20-613
335-527		X-ray2.90hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.62
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.340.6298.480.38 20-613
333-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.3599.240.38 20-613
332-528		X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.63
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.3699.870.38 20-613
333-530		X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCBLAST / HHblits0.63
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.3498.100.38 20-613
333-527		X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMABLAST / HHblits0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.3598.100.38 20-613
333-527		EM0.00hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.3598.100.38 20-613
333-527		EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGBLAST / HHblits0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.3598.100.38 20-613
333-527		EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7xaz.1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.3697.970.38 20-613
333-527		X-ray3.00hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.62
7xaz.2
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.3697.970.38 20-613
333-527		X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7xb0.1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
0.3597.970.38 20-613
333-527		X-ray2.90hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGBLAST / HHblits0.62
7p19.1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
0.3699.880.39 19-615
334-541		X-ray3.24hetero-1-1-mer3 x NAG, 1 x ZNBLAST / HHblits0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.3597.730.38 19-613
331-529		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3597.250.38 19-615
327-531		X-ray2.85hetero-1-1-mer1 x ZN, 6 x NAGBLAST / HHblits0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.3599.870.38 20-614
328-530		X-ray2.78hetero-1-1-mer1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.63
7l0n.2
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.3699.870.38 20-614
328-530		X-ray2.78hetero-1-1-mer1 x ZN, 5 x NAG, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.63
7xbh.1
The complex structure of RshSTT182/200 RBD bound to human ACE2
0.350.6396.340.39 18-619
319-541		X-ray3.02hetero-1-1-mer5 x NAG, 1 x ZNBLAST0.62
7zf7.1
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2
0.3698.000.38 20-615
330-532		X-ray3.46hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.3599.870.38 20-614
328-531		X-ray2.78hetero-1-1-mer1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST / HHblits0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.3598.120.38 19-613
330-530		EM0.00hetero-1-1-mer7 x NAGBLAST0.62
7p19.1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
0.3599.880.39 19-614
334-541		X-ray3.24hetero-1-1-mer3 x NAG, 1 x ZNHHblits0.63
7p19.2
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
0.3699.880.39 19-614
334-541		X-ray3.24hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.040.39 19-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMABLAST / HHblits0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.040.39 19-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGBLAST / HHblits0.62
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.3799.880.39 19-614
319-527		X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.3597.730.38 20-613
331-529		EM0.00hetero-1-1-mer7 x NAGHHblits0.62
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.37100.000.39 19-614
319-527		X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.63
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3597.250.38 20-615
327-531		X-ray2.85hetero-1-1-mer1 x ZN, 6 x NAGHHblits0.62
7tn0.2
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3697.250.38 20-615
327-531		X-ray2.85hetero-1-1-mer5 x NAG, 1 x ZNHHblits0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3597.760.39 19-615
324-531		X-ray2.85hetero-1-1-mer1 x ZN, 6 x NAGBLAST0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3697.910.39 19-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.910.39 19-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGBLAST0.62
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.3696.520.39 19-615
319-527		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.62
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.3598.110.38 20-613
330-530		EM0.00hetero-1-1-mer7 x NAGBLAST / HHblits0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.030.39 20-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.030.39 20-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGHHblits0.62
7xbh.1
The complex structure of RshSTT182/200 RBD bound to human ACE2
0.340.6193.890.39 18-619
319-541		X-ray3.02hetero-1-1-mer5 x NAG, 1 x ZNBLAST / HHblits0.60
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.360.5796.650.39 19-615
319-527		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.3597.760.39 20-615
324-531		X-ray2.85hetero-1-1-mer1 x ZN, 6 x NAGBLAST / HHblits0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3697.910.39 20-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMABLAST / HHblits0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.3597.910.39 20-617
322-536		X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGBLAST / HHblits0.62
7dmu.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.3599.010.39 18-615
319-531		X-ray3.20hetero-1-1-mer1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMABLAST / HHblits0.63
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.3799.880.39 20-613
319-527		X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7dmu.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.3699.140.39 18-615
319-531		X-ray3.20hetero-1-1-mer1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.63
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.370.55100.000.39 20-613
319-527		X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.63
7efr.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
0.3699.630.39 19-615
321-537		X-ray2.49hetero-1-1-mer5 x NAGBLAST / HHblits0.63
7efr.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
0.3699.750.39 19-615
321-537		X-ray2.49hetero-1-1-mer5 x NAGBLAST0.63
7dmu.2
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.3599.010.39 19-615
319-531		X-ray3.20hetero-1-1-mer2 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAGHHblits0.63
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.3696.510.39 20-614
319-527		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.62
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.3799.880.39 19-615
319-541		X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.3599.630.39 19-615
319-541		EM0.00hetero-1-1-mer3 x NAGBLAST / HHblits0.63
7efp.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
0.3599.750.39 20-615
320-537		X-ray2.70hetero-1-1-mer5 x NAGBLAST / HHblits0.63
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.37100.000.39 19-615
319-541		X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.3699.760.39 19-615
319-541		EM0.00hetero-1-1-mer3 x NAGBLAST0.63
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.3696.640.39 20-614
319-527		EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.62
7efp.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
0.3599.880.39 20-615
320-537		X-ray2.70hetero-1-1-mer5 x NAGBLAST0.63
6vw1.1
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.3696.190.39 19-615
319-535		X-ray2.68hetero-1-1-mer1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.62
6vw1.2
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.350.6096.190.39 19-615
319-535		X-ray2.68hetero-1-1-mer1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAGBLAST0.62
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.3799.880.39 20-615
319-541		X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.63
7ekh.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
0.370.5599.760.39 20-615
319-541		X-ray2.40hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7eke.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
0.3799.760.39 20-615
319-541		X-ray2.70hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7ekf.1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
0.3799.760.39 20-615
319-541		X-ray2.85hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.3599.630.39 20-615
319-541		EM0.00hetero-1-1-mer3 x NAGHHblits0.63
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.37100.000.39 20-615
319-541		X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGBLAST / HHblits0.63
7ekh.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
0.3799.880.39 20-615
319-541		X-ray2.40hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.63
7eke.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
0.3799.880.39 20-615
319-541		X-ray2.70hetero-1-1-mer4 x NAG, 1 x ZNBLAST / HHblits0.63
7ekg.1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
0.3799.510.39 20-615
319-541		X-ray2.63hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7ekc.1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
0.3799.510.39 20-615
319-541		X-ray2.80hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.3699.760.39 20-615
319-541		EM0.00hetero-1-1-mer3 x NAGBLAST / HHblits0.63
7ekf.1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
0.3799.880.39 20-615
319-541		X-ray2.85hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.63
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3599.260.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.62
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3499.260.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.62
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3699.260.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.62
7ekg.1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
0.3799.630.39 20-615
319-541		X-ray2.63hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.63
7ekc.1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
0.3799.630.39 20-615
319-541		X-ray2.80hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.63
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3599.390.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3499.390.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3699.390.39 19-615
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7p8i.1
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.350.5196.200.39 19-615
319-541		X-ray4.50hetero-1-1-mer2 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7p8i.2
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.3596.200.39 19-615
319-541		X-ray4.50hetero-1-1-mer3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7p8i.1
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.3697.320.39 19-615
319-541		X-ray4.50hetero-1-1-mer2 x NAG-NAG, 3 x NAG-NAG-BMABLAST / HHblits0.62
7p8i.2
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.3697.320.39 19-615
319-541		X-ray4.50hetero-1-1-mer3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMABLAST / HHblits0.62
7xbf.1
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.350.5496.230.40 18-615
316-541		X-ray3.51hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.62
7xbf.2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.3596.230.40 18-615
316-541		X-ray3.51hetero-1-1-mer5 x NAG, 1 x ZNBLAST0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.350.5996.190.39 19-614
319-541		X-ray3.09hetero-1-1-mer4 x NAG, 1 x ZN, 2 x NAG-NAGBLAST / HHblits0.61
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.3596.190.39 19-614
319-541		X-ray3.09hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAGBLAST / HHblits0.61
6vw1.1
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.3696.180.39 20-614
319-535		X-ray2.68hetero-1-1-mer1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAGBLAST / HHblits0.62
6vw1.2
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.350.5996.180.39 20-614
319-535		X-ray2.68hetero-1-1-mer1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAGBLAST / HHblits0.62
7wbq.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.3598.770.39 20-613
319-541		X-ray3.34hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FULHHblits0.62
7wbq.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.3598.770.39 20-613
319-541		X-ray3.34hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.360.5997.310.39 19-614
319-541		X-ray3.09hetero-1-1-mer4 x NAG, 1 x ZN, 2 x NAG-NAGBLAST0.62
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.3697.310.39 19-614
319-541		X-ray3.09hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAGBLAST0.62
7u0n.2
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
0.3595.440.39 20-614
319-534		X-ray2.61hetero-1-1-mer3 x NAG, 1 x ZN, 1 x MG, 3 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7ufk.2
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
0.350.5495.310.39 20-614
319-534		X-ray2.38hetero-1-1-mer1 x ZN, 3 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.61
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3499.260.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3499.260.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3699.260.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.4
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3599.260.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7wbq.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.3699.760.39 20-613
319-541		X-ray3.34hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FULBLAST / HHblits0.63
7u0n.1
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
0.3595.440.39 20-614
319-535		X-ray2.61hetero-1-1-mer5 x NAG, 1 x ZN, 2 x NAG-NAG-BMABLAST / HHblits0.61
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3599.380.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3499.380.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3699.380.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.63
7rpv.4
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.3599.380.39 20-614
320-537		X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.63
7ufk.1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
0.3695.320.39 20-614
319-535		X-ray2.38hetero-1-1-mer1 x ZN, 5 x NAG, 2 x NAG-NAG-BMABLAST / HHblits0.61
7wbp.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
0.3697.670.39 20-613
319-541		X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7wbp.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
0.3698.160.39 20-613
319-541		X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST / HHblits0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.350.5996.180.39 20-613
319-541		X-ray3.09hetero-1-1-mer4 x NAG, 1 x ZN, 2 x NAG-NAGHHblits0.61
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.3596.180.39 20-613
319-541		X-ray3.09hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAGHHblits0.61
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.360.5997.310.39 20-613
319-541		X-ray3.09hetero-1-1-mer4 x NAG, 1 x ZN, 2 x NAG-NAGBLAST / HHblits0.62
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.3697.310.39 20-613
319-541		X-ray3.09hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAGBLAST / HHblits0.62
7fdk.1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
0.3488.380.39 1-615
333-526		EM0.00hetero-1-1-mer3 x NAGBLAST / HHblits0.59
7fdk.1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
0.3488.130.39 1-615
332-526		EM0.00hetero-1-1-mer3 x NAGHHblits0.59
7xbf.1
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.350.5393.410.40 18-615
297-541		X-ray3.51hetero-1-1-mer6 x NAG, 1 x ZNBLAST / HHblits0.60
7xbf.2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.3593.410.40 18-615
297-541		X-ray3.51hetero-1-1-mer5 x NAG, 1 x ZNBLAST / HHblits0.60
7ufl.1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
0.3592.000.39 19-615
319-534		X-ray2.84hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMABLAST / HHblits0.60
7ufl.2
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
0.3492.000.39 19-615
319-534		X-ray2.84hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMABLAST / HHblits0.60
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.3590.520.38 19-615
335-528		X-ray2.89hetero-1-1-mer5 x NAGBLAST / HHblits0.60
7fc6.1
Crystal structure of SARS-CoV RBD and horse ACE2
0.3383.850.38 19-615
335-526		X-ray2.65hetero-1-1-mer2 x NAG, 1 x NAG-NAGBLAST / HHblits0.57
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.350.5290.550.38 19-615
333-529		X-ray2.89hetero-1-1-mer5 x NAGBLAST0.60
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.3590.480.38 20-613
335-528		X-ray2.89hetero-1-1-mer5 x NAGHHblits0.60
7fc6.1
Crystal structure of SARS-CoV RBD and horse ACE2
0.3283.780.37 20-613
335-526		X-ray2.65hetero-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.57
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.350.5290.520.38 20-613
333-529		X-ray2.89hetero-1-1-mer5 x NAGBLAST / HHblits0.60
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.850.38 19-615
335-527		X-ray3.01hetero-1-1-mer3 x NAGBLAST / HHblits0.59
7f5r.1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.880.38 19-615
333-527		X-ray3.01hetero-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-FUCBLAST0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.880.38 19-615
333-527		X-ray3.01hetero-1-1-mer3 x NAGBLAST0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.820.38 20-614
335-527		X-ray3.01hetero-1-1-mer3 x NAGHHblits0.59
7f5r.3
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.820.38 20-614
335-527		X-ray3.01hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.59
7f5r.1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.850.38 20-614
333-527		X-ray3.01hetero-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-FUCBLAST / HHblits0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.3487.850.38 20-614
333-527		X-ray3.01hetero-1-1-mer3 x NAGBLAST / HHblits0.59
7f5r.3
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.350.5887.850.38 20-614
333-527		X-ray3.01hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST / HHblits0.59
7dhx.1
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
0.3589.070.39 18-614
319-527		X-ray2.30hetero-1-1-mer2 x NAG, 1 x ZNBLAST / HHblits0.59
7dhx.1
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
0.360.4989.210.39 18-614
319-527		X-ray2.30hetero-1-1-mer2 x NAG, 1 x ZNBLAST0.59
7w6u.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
0.350.5590.700.39 20-614
319-541		X-ray2.56hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.60
7w6u.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
0.3690.830.39 20-614
319-541		X-ray2.56hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.60
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.340.5386.980.39 19-614
319-541		X-ray2.60hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.350.5388.160.39 19-614
319-541		X-ray2.60hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.59
7wsk.1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
0.3386.970.40 18-617
319-541		X-ray3.30hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-MANBLAST / HHblits0.58
7wsk.1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
0.340.5687.480.40 18-617
319-541		X-ray3.30hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-MANBLAST0.59
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.340.5386.960.39 20-614
319-541		X-ray2.60hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.58
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.350.5388.140.39 20-614
319-541		X-ray2.60hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.320.5288.280.39 19-615
319-541		EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGBLAST / HHblits0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.3288.410.39 19-615
319-541		EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGBLAST0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.320.5288.160.39 20-616
319-541		EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGHHblits0.59
7wa1.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with American mink ACE2
0.3688.160.39 20-616
319-541		EM0.00hetero-1-1-mer1 x ZNHHblits0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.3288.290.39 20-616
319-541		EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGBLAST / HHblits0.59
7xa7.1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3584.880.39 18-615
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7xa7.2
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3584.880.39 18-615
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7xa7.4
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3584.880.39 18-615
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7xa7.1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3585.020.40 18-615
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.58
7xa7.2
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3585.020.40 18-615
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.58
7xa7.3
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3584.840.39 19-614
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.58
7xa7.3
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.3584.980.39 19-614
319-541		X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST / HHblits0.58
7wpz.1
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
0.3264.320.38 20-616
330-526		EM0.00hetero-1-1-mer4 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANBLAST / HHblits0.50
7wpz.1
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
0.3263.970.38 21-615
330-526		EM0.00hetero-1-1-mer4 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.49